Furthermore, low dose of AME treatment increased the ratio of pAkt/Akt and high dose of AME treatment increased the protein level of GLUT4 in T2DM mice (Figure 3B). This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.